During its fifteen years, PEPFAR has become one of the most important global health initiatives ever launched. However, its influence is fading, threatening the global fight against HIV/AIDS as the struggle against the pandemic faces a turning point.
With the United States likely to pull back on global health funding, the World Health Organization, under its new director-general, will need to undertake serious structural and administrative changes.
A surge in deaths in China from a virulent form of influenza has set off a scramble among health officials to find infected bird stocks, while experts have yet to produce a viable vaccine, writes CFR’s Laurie Garrett.
Dame Sally Davies discusses the challenges of responding to antimicrobial resistance (AMR) and the need for a global action plan following the high level meeting on Antimicrobial Resistance at the United Nations General Assembly.
To contain infectious disease outbreaks like Zika and Ebola, global health authorities must learn from past efforts to motivate the private and nonprofit sectors around problems of the poor, write CFR’s Thomas Bollyky and PATH CEO Steve Davis.